Cargando…
In Which Patients with Sarcoidosis Is FDG PET/CT Indicated?
Sarcoidosis is a granulomatous disease of which the etiology remains unknown. The diverse clinical manifestations may challenge clinicians, particularly when conventional markers are inconclusive. From various studies, it has become clear that fluorodeoxyglucose (FDG) positron emission tomography (P...
Autores principales: | Keijsers, Ruth G.M., Grutters, Jan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141490/ https://www.ncbi.nlm.nih.gov/pubmed/32213991 http://dx.doi.org/10.3390/jcm9030890 |
Ejemplares similares
-
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
por: Mathijssen, H., et al.
Publicado: (2021) -
Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis
por: Schimmelpennink, Milou C., et al.
Publicado: (2019) -
Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019) -
Pericardial sarcoidosis presenting as PUO diagnosed on FDG PET CT scan
por: Vasantrao, Solav Shrikant, et al.
Publicado: (2020) -
FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment
por: Inoue, Kentaro, et al.
Publicado: (2013)